Aptorum Group Limited (NASDAQ:APM) Short Interest Down 6.9% in October

Aptorum Group Limited (NASDAQ:APM) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 19,000 shares, a decrease of 6.9% from the October 15th total of 20,400 shares. Based on an average trading volume of 147,400 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.5% of the company’s shares are short sold.

Aptorum Group Trading Up 0.6 %

NASDAQ:APM opened at $1.55 on Friday. The firm’s fifty day simple moving average is $2.00 and its 200 day simple moving average is $2.45. Aptorum Group has a twelve month low of $1.38 and a twelve month high of $9.00.

Institutional Investors Weigh In On Aptorum Group

An institutional investor recently raised its position in Aptorum Group stock. Geode Capital Management LLC increased its position in Aptorum Group Limited (NASDAQ:APM) by 1.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 353,302 shares of the company’s stock after purchasing an additional 5,550 shares during the quarter. Geode Capital Management LLC owned approximately 9.90% of Aptorum Group worth $194,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 13.89% of the company’s stock.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.